HAVN Life Sciences Inc. (CSE: HAVN) Featured in Coverage of Investor Summit Group’s Q3 Virtual Event
HAVN Life Sciences Inc. (CSE: HAVN) is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will…